<DOC>
	<DOCNO>NCT00731770</DOCNO>
	<brief_summary>Fluticasone , inhale corticosteroid salmeterol , long-acting beta agonist , approve use management COPD . Fluticasone/salmeterol show significantly improve FEV1 decrease COPD symptom ( Calverley et al . 2003 , 2007 ) . Inhaled corticosteroid show decrease frequency COPD exacerbation ( Gartlehner et al . 2006 ) long act bronchodilator demonstrate reduction dyspnea , increase airflow reduction hyperinflation patient symptomatic COPD ( Ramirez-Venegas et al . 1997 ) . Specifically , salmeterol also show positive effect symptom health status patient COPD add usual treatment ( Stockley et al . 2006 ) . Previous research subject group asthma show salmeterol associate sustained improvement morning PEF , protection nighttime lung function deterioration improvement patient perception sleep ( Wiegand et al . 1999 ) . This study perform patient COPD effect salmeterol fluticasone sleep quality assess . AIM : The aim study determine effect fluticasone/salmeterol sleep quality patient COPD compare efficacy Advair 250 compare placebo sleep . The hypothesis would significant improvement sleep quality patient place fluticasone/salmeterol compare placebo .</brief_summary>
	<brief_title>Comparing Fluticasone-Salmeterol Chronic Obstructive Pulmonary Disease ( COPD ) Sleep</brief_title>
	<detailed_description>RATIONALE : Chronic obstructive pulmonary disease ( COPD ) term describes disease state chronic irreversible airflow limitation . It well document patient COPD disturb sleep . Certain published report suggest 50 % COPD patient sleep complaint ( George et al. , Drugs , 2003 ) . These patient find sleep onset latency poor sleep maintenance . While sleep disturbance may explain part side effect medication , could also result nocturnal gas exchange abnormality ( Knutty 2004 ) . In COPD worsen hypoxemia hypercapnia sleep , particularly REM sleep , sleep disturbance seem bad severe COPD . It commonly believe optimize medical management disease important improve sleep quality patient thus lead improve quality life . Fluticasone , inhale corticosteroid salmeterol , long-acting beta agonist , approve use management COPD . Fluticasone/salmeterol show significantly improve FEV1 decrease COPD symptom ( Calverley et al . 2003 , 2007 ) . Inhaled corticosteroid show decrease frequency COPD exacerbation ( Gartlehner et al . 2006 ) long act bronchodilator demonstrate reduction dyspnea , increase airflow reduction hyperinflation patient symptomatic COPD ( Ramirez-Venegas et al . 1997 ) . Specifically , salmeterol also show positive effect symptom health status patient COPD add usual treatment ( Stockley et al . 2006 ) . Previous research subject group asthma show salmeterol associate sustained improvement morning PEF , protection nighttime lung function deterioration improvement patient perception sleep ( Wiegand et al . 1999 ) . This study perform patient COPD effect salmeterol fluticasone sleep quality assess . AIM : The aim study determine effect fluticasone/salmeterol sleep quality patient COPD compare efficacy Advair 250 compare placebo sleep . The hypothesis would significant improvement sleep quality patient place fluticasone/salmeterol compare placebo .</detailed_description>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<criteria>1 . Patients moderate severe COPD per GOLD criterion 2 . Insomnia , poor sleep , nonrestorative sleep daytime sleepiness history 3 . Age 45 75 year , male female 4 . FEV1 80 % predict use CRAPO 5 . FEV1/FVC &lt; 70 % predict 6 . Past present tobacco smoker 7 . Female patient must postmenopausal 1 year willing use birth control abstain sex . 1 . Asthma 2 . Use oral injectable corticosteroid within 2 month 3 . Previous diagnosis sleep disorder breathing ( sleep apnea , narcolepsy , etc . ) 4 . Lung heart disease except COPD 5 . Deviated nasal septum , nasal polyp anatomic obstruction nose 6 . Obesity define BMI &gt; 30kg/m2 7 . Inability tolerate history allergy long act beta agonist inhale corticosteroid therapy . 8 . Inability complete 2 week runin albuterol prn therapy 9 . Use narcotic , sleep aid , sedate antihistamine , sedative , MAO Inhibitors , medication know affect daytime somnolence sleep quality 10 . Excessive use alcohol use `` recreational drug '' 11 . Use narcotic , sleep aid , sedative sedate antihistamine . 12 . Night shift worker 13 . Women breast feed pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>COPD</keyword>
	<keyword>sleep</keyword>
	<keyword>daytime somnolence</keyword>
</DOC>